The problem {#Sec1}
===========

Many would consider sudden infant death syndrome (SIDS) to be an uncontroversial, largely solved problem of infant safety, yet it remains a leading cause of infant mortality in the developed world. Efforts in diagnosis, surveillance, research, and prevention are complicated by substantial divergence in certification and coding of these deaths \[[@CR1], [@CR2]\]. At the center of this divergence is the very concept of SIDS. Although the term SIDS is endorsed by the World Health Organization (WHO) and is broadly used by physicians, researchers, and the public, it is increasingly avoided by forensic pathologists in many jurisdictions who determine cause and certify sudden deaths in infants \[[@CR1]\].

There are three basic issues that have contributed to difficulties with the diagnosis of SIDS. First, there have long been questions among forensic pathologists about the evidence required to apply a diagnosis of exclusion. Even with formal death scene investigations, evidence often has uncertain implications. Second, it has become the practice in many jurisdictions for forensic pathologists to refrain from using the diagnosis of SIDS under any circumstances. Third, once deaths have been certified by pathologists, surveillance requires an interface between death certificates and ICD codes and coding algorithms, a process that sometimes leads to an entered diagnostic code (classification) that is different than the certifier's intention. These factors contribute to diagnostic shift, where reported declines in SIDS rates are exaggerated by the attribution of these deaths to other causes \[[@CR3]\]. This reassignment, towards "undetermined/unascertained" or "asphyxia" occurring in a sleep environment, serves to underestimate the actual mortality of what was once considered SIDS. The phenomenon is seen in virtually every advanced economy \[[@CR4]\], although lessened in Scandinavia due to regional consensus \[[@CR5]\] (Fig. [1a](#Fig1){ref-type="fig"}). While some countries report decreases in SIDS since initial declines in the early 1990's, one implication of this reassignment, particularly in the United States (US), is that over half of what was once SIDS is now counted otherwise (Fig. [1b](#Fig1){ref-type="fig"}). Alternative classifications, each with different terminology and definitions have not achieved consensus, but instead have contributed to discordant use of terminology and acronyms (Table [1](#Tab1){ref-type="table"}). For example, although the acronyms SUID or SUDI are often assumed to be interchangeable, the "U" modifying sudden infant death may represent unexpected, undetermined, unknown, unexplained, or unascertained in actual usage \[[@CR6]--[@CR8]\]. While SUID/SUDI has its origins as an umbrella term for the initial presentation of ultimately explained or unexplained infant deaths, it is commonly used by death certifiers as an alternative to a final SIDS diagnosis. Interested parties have failed to agree on the definition and terminology for the leading cause of postneonatal mortality \[[@CR6], [@CR7], [@CR9]--[@CR14]\]. Current classification practices have poor reliability and undermine accounting of progress \[[@CR15]\].Fig. 1Evidence for diagnostic shift. Multinational comparison of diagnostic preferences (a) and time study of US trends (b). **a** International classification of diseases-10 (ICD-10) codes as percentages of the total sudden unexpected deaths in infancy per country, 2002--2010. Modified from Taylor et al. \[[@CR4]\]. **b** Proportionate use of unexplained infant death categories in the United States, 1990--2016. Modified from Erck Lambert et al. \[[@CR31]\]Table 1Terminology and previously proposed diagnostic schemaSudden infant death syndrome (SIDS)Sudden unexpected infant death (SUID)Sudden unexplained infant death (SUID)Sudden unexpected death in infancy (SUDI)Beckwith, 2nd International SIDS Conference^6^XWillinger, US National Institute for Child Health and Development^7^XGilbert^8^XKrous^9^XCorey, National Association of Medical Examiners^10^XRandall^13^XFleming and Blair, Avon^12^XShapiro-Mendoza, Centers for Disease Control SUID Registry^11^X

The international adoption of SIDS terminology in 1969 was intended to identify infants dying from unknown causes in order to investigate their deaths as a distinct but unexplained entity in infancy. The core phenomenon included the relative sparing of deaths in the newborn period, concentration of unexplained mortality between 2 and 6 months, a relationship with sleep, and non-specific but prevalent findings on autopsy. Ensuing epidemiological research found risks associated with infant sleep environments \[[@CR16]\], which in turn spurred public health efforts and led to a worldwide transformation in infant care practices and the promotion of formal death scene investigations \[[@CR17]\]. Indications of underlying pathology and biological processes were discovered in many of these infants, including intrathoracic petechiae \[[@CR18]\], brainstem gliosis \[[@CR19]\], brainstem serotonin deficiencies \[[@CR20]\], epilepsy-associated neuropathological findings \[[@CR21]\], associations with prenatal alpha-fetoprotein \[[@CR22]\], associations with antenatal alcohol and tobacco exposure \[[@CR23]\], and genetic findings \[[@CR24], [@CR25]\]. However, diverging opinions emerged in interpreting the relative roles of extrinsic factors and underlying biological processes.

The impasse was not without reason. The importance of autopsy findings and sleep environment observations are often difficult to estimate, and terminal events generally remain a matter of speculation. The triple risk theory \[[@CR26]\], the leading etiologic framework for SIDS, proposes that extrinsic factors become lethal in an infant with intrinsic vulnerabilities when challenged at critical developmental ages, but those extrinsic factors are not uniformly lethal. Multiple environmental risk factors for SIDS (prone sleep position, bed/surface sharing, soft bedding or blankets) are often found, but interpreting whether the evidence confirms accidental asphyxia is challenging and inconsistently concluded. Furthermore, some autopsy findings are non-specific and may be identical in deaths from SIDS, asphyxia (accidental or homicidal), or natural diseases such as arrhythmias and metabolic disorders. Additionally, while extrinsic factors in an infant's sleep environment are typically noted, features that may influence underlying biologic processes often do not receive attention (smoking during pregnancy, in utero alpha-fetoprotein levels, brainstem serotonin levels, epilepsy in-situ). If there is agreement that there exists an incompletely understood entity involving intrinsic biological and environmental factors, there is disagreement about how to assess these factors uniformly.

There are difficulties related to classification. Coding algorithms may assign these deaths to classifications that the certifier did not intend. For example, a death certificate reading undetermined/unascertained with mention of possible asphyxia due to bed sharing is coded as accidental suffocation and strangulation in bed (ASSB) by WHO coding algorithms, in effect elevating risk factor to cause in classification. A case with identical details might be certified as SIDS or undetermined without mention of risk factors or possible cause of death by other certifiers. Finally, there are important human aspects of this problem, devastating to a family on many levels. On the level of those affected, bereaved parents associate blame and judgment with the use of different terms \[[@CR27]\], with ASSB and undetermined cause of death carrying a stigma of implied blame, even when evidence does not support that parents have caused harm. Parents suffer from severe grief-related symptoms \[[@CR28]\], and few options are available to obtain enhanced diagnostics for better explanations, despite recent advances in undiagnosed diseases \[[@CR29]\].

The proceedings {#Sec2}
===============

The World Health Organization periodically releases an updated manual for the international classification of diseases (ICD). The current revision (ICD-11) is in its final stages before planned implementation in 2022. The 3rd International Congress on Sudden Infant and Child Death was convened to align the current scientific understanding of sudden unexpected death in infancy/childhood with certification and coding nomenclature. It sought a practical consensus on essential characteristics of this category of mortality and the best nomenclature to reflect this. In attendance were representatives of the Centers for Disease Control and Prevention (US), National Association of Medical Examiners (US, Canada), American Academy of Pediatrics (US), the International Society for the Study and Prevention of Perinatal and Infant Death (International), leading basic science and epidemiological researchers from around the world (US, UK, Norway, Germany, New Zealand), and included pediatricians, pediatric pathologists, forensic pathologists, family physicians, epidemiologists, statisticians, researchers, and parent representatives.

It was first necessary to agree on the precise use of the terms unexpected, unexplained, unascertained and undetermined. As originally conceived, SIDS refers to "the sudden death of any infant or young child, which is unexpected by history, and in which a thorough post-mortem investigation fails to demonstrate an adequate cause for death" \[[@CR9]\]. In recent years, a thorough post-mortem investigation has included appropriate laboratory testing \[[@CR7]\]. By convention, "unexpected" denotes a preliminary designation pending investigation. If the investigation does not reveal a cause, cases are designated as "unexplained". Deaths where investigations are incomplete or competing defined causes preclude final certification warrant the designation "undetermined" (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Consensus for recommended use of the terms unexpected, unexplained, undetermined, and explained subsets. The Congress reviewed, clarified and recommended terminology relative to the process of case determination

Differing perspectives on the evidence required before using the diagnostic categories of undetermined or suffocation/asphyxia death were discussed. Despite diagnostic criteria that include complete investigations, actual practice and available resources vary. Death certification involves a determination of both cause and manner, and the Radcliffe Congress placed emphasis on objective evidence to support conclusions for cause. The presence of sleep environment risk factors without adequate evidence for airway obstruction or chest wall compression were considered insufficient to certify a death due to asphyxia. The need for stringent criteria before using "undetermined" or asphyxia, categories that shift away from SIDS, was emphasized, along with the need for precise, descriptive terminology. There was affirmation that once abuse, neglect and trauma are eliminated, the needs of the family should be prioritized by clearly explaining the strength of the evidence for why the infant died and potential implications to them.

Recommendations {#Sec3}
===============

After two days of debate, the following conclusions were unanimously reached (Table [2](#Tab2){ref-type="table"}, with definitions for death certifiers in the caption). Refinements were proposed to four relevant diagnostic categories (ICD-11 categories of MH11, MH12, MH14, PB00-PB0Z) to be recommended for content enhancement to the WHO, and explicit definitions and guidance were provided for death certifiers. A title change from "SIDS" to "Unexplained Sudden Death in Infancy or SIDS", using the definition established by the (US) National Association of Medical Examiners \[[@CR7]\], was recommended for the MH11 category to emphasize that either term signifies the lack of explanation following a rigorous investigation. This definition describes the death of an infant less than 1 year of age, in which investigation, autopsy, medical history review, and appropriate laboratory testing fails to identify a specific cause of death, and includes cases that meet the definition of sudden infant death syndrome. The use of "unexplained sudden death in infancy" without acronym acknowledged the difficulties of having acronyms with different interpretations and also addressed objections by some medical examiners that the term" SIDS" should not be used under any circumstances. The simultaneous inclusion of "SIDS" within the MH11 category confirmed both the historical importance of this term and the recognition that there may be identifiable intrinsic vulnerabilities contributing to the death whose examination is not included in a standard investigation (e.g. serotonin deficiencies in the ventral medulla, epilepsy-in-situ in the dentate gyrus, pathogenic genetic variants) or yet-to-be identified vulnerabilities that are the focus of future research. A subcategory MH11.1 for unexplained sudden deaths in infancy or SIDS without mention of autopsy recognizes that there are communities and cultures within which autopsies are not regularly completed due to lack of resources or cultural norms (e.g. religious objections); inclusion of this category will allow these deaths to be included for research and statistical purposes. A formalized emphasis for similar unexplained sudden deaths in children over the age of 1, beyond "other sudden death," within the MH12 category that includes adults, was also recommended, to improve surveillance of an increasingly recognized category of unexplained child deaths. Explicit guidance was provided for the use of the alternative categories of "accidental asphyxia" and "undetermined", with recommendations for essential requirements before their use in these cases. Acronyms were discouraged to prevent future misconceptions. Unexplained sudden death in infancy or SIDS on a death certificate will code a unique, trackable entity, accurately reflecting the inability to determine a definitive explanation, while satisfying surveillance needs and reliable identification for research efforts. These recommendations will be immediately proposed to the WHO for the ICD-11. In addition, the recommendations will be disseminated among international forensic pathology and pediatric organizations.Table 2Consensus classification of unexplained sudden deaths in infants and childrenProposed ICD-11 CodeCurrent ICD-10 CodeProposed ICD-11 Stem Code/ClassificationICD-10 ClassificationNotes for Death CertifiersMH11R95Unexplained sudden death in infancy or Sudden Infant Death SyndromeSudden Infant Death SyndromeaMH11.0R95.0Unexplained sudden death in infancy or Sudden Infant Death Syndrome, with mention of autopsySudden Infant Death SyndromeaMH11.1R95.9Unexplained Sudden Death in Infancy or Sudden Infant Death Syndrome, without mention of autopsySudden Infant Death SyndromeaMH12R96Unexplained sudden death in children and adultsOther sudden death, cause unknownbMH12.0Unexplained sudden death in children and adults, with mention of autopsybMH12.1Unexplained sudden death in children and adults, without mention of autopsybMH14R99Other Ill-Defined or Unspecified Causes of Death (Undetermined)Other Ill-Defined or Unspecified Causes of Deathc, dPB00-PB0ZW75-W84Unintentional threat to breathing (accidental asphyxia)Unintentional threat to breathing by external compression of airways or chest; Unintentional threat to breathing by unspecified meanse, fa:The sudden unexpected death of an apparently healthy infant under one year of age that remains unexplained after a thorough case investigation, including performance of a complete autopsy with ancillary testing, examination of the death scene, and review of the clinical historyb: The sudden unexpected death of a person one year of age or older that remains unexplained after a thorough case investigation, including performance of a complete autopsy with ancillary testing, and review of the clinical history and circumstances of deathc: Cases may be certified as undetermined when: the investigation, death scene examination, or autopsy was substantially limited, incomplete or insufficient, for example legal/religious restrictions, delayed report of death that limits scene investigation, or decomposition; or when inconsistent accounts or other findings raise competing conclusions about the cause of deathd: Infant deaths with adequate death scene investigation and autopsy, with a history of bed/sleep surface sharing, soft bedding, or non-supine sleep, and without physical evidence of asphyxia, may be more appropriately certified as unexplained sudden death in infancy or sudden infant death syndromee: Certification of asphyxia: Adequate evidence must be documented to substantiate asphyxiation, given the decedent's age and stage of development. There cannot be a reasonable competing cause of death after a complete autopsy with ancillary testing, examination of the death scene (with a doll re-enactment when appropriate), and review of the clinical historyf: In infants, bed/sleep surface sharing, soft bedding, or prone sleep, without adequate evidence for airway obstruction or chest wall compression, are insufficient to certify a death as due to asphyxia. These deaths may be more appropriately certified as unexplained sudden death or SIDS. The use of "possible" or "probable" asphyxia will result in the death being classified as asphyxia

Conclusions {#Sec4}
===========

Sudden death in infants remains a distinct and tragic category of death, and terminal events remain a matter of speculation in most cases. While different medical constituencies may prioritize different aspects of unexplained deaths, progress was made to increase the reliability of the category. With broad representation and an insistence on consensus, the Radcliffe Congress succeeded in 1) articulating definitions for the classification of unexplained sudden deaths in infants and children; 2) discriminating categories with explicit guidance for death certifiers in the use of alternative diagnoses; and 3) providing an approach for dissemination. If implemented, the reported incidence of unexplained sudden death in infancy or sudden infant death syndrome/MH11 will more accurately account for cases that would otherwise be lost in diagnostic shift. The diagnostic category of "unexplained sudden death in children and adults/MH12" will improve international surveillance of similar deaths in children beyond infancy \[[@CR30]\]. The mutual understanding gained at the Radcliffe Congress promises better future collaboration in addressing this persistent, heartbreaking matter of infant and child mortality.
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